Tokyo, March 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061011) titled 'Follow-up study after "A Single-Center, Single-Arm Study to Evaluate the Efficacy of Antibiotics-combined Fecal Microbiota Transplantation in Active Crohn's Disease"' on March 23.
Study Type:
Observational
Primary Sponsor:
Institute - Juntendo University
Condition:
Condition - Crohn's Disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the efficacy of maintenance in patients who have completed A-FMT treatment and post evaluation after 8 weeks
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 16
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who participated in the ongoing clinical study titled "A Single-Center, Single-Arm Study to Evaluate the Efficacy of Antibiotics-combined Fecal Microbiota Transplantation in Active Crohn's Disease".
Key exclusion criteria - Patients deemed unsuitable as subjects by the principal investigator
Target Size - 20
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 09 Month 30 Day
Date of IRB - 2025 Year 09 Month 30 Day
Anticipated trial start date - 2026 Year 03 Month 23 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067793
Disclaimer: Curated by HT Syndication.
